Evidence map›Paper›PMID 21390255›Full record

ArticlePloS one2011

Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus.

Eleanor R Gaunt, Rogier R Jansen, Yong Poovorawan, Kate E Templeton, Geoffrey L Toms, Peter Simmonds

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Insights from respiratory virus co-infections.World journal of virology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Impact of RSV-Associated Respiratory Disease on Children in Asia.Journal of pediatric infectious diseases · 2019
    Review
  14. Article
  15. 180-Nucleotide Duplication in the G Gene ofFrontiers in microbiology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Recent vaccine development for human metapneumovirus.The Journal of general virology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Eleanor R GauntCentre for Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom. e.gaunt@sms.ed.ac.uk
Rogier R Jansen
Yong Poovorawan
Kate E Templeton
Geoffrey L Toms
Peter Simmonds
University of Edinburgh · GBAcademic Medical Center · NLChulalongkorn University · THEdinburgh Royal Infirmary · GBNewcastle University · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are ubiquitous respiratory pathogens of the Pneumovirinae subfamily of the Paramyxoviridae. Two major surface antigens are expressed by both viruses; the highly conserved fusion (F) protein, and the extremely diverse attachment (G) glycoprotein. Both viruses comprise two genetic groups, A and B. Circulation frequencies of the two genetic groups fluctuate for both viruses, giving rise to frequently observed switching of the predominantly circulating group. Nucleotide sequence data for the F and G gene regions of HRSV and HMPV variants from the UK, The Netherlands, Bangkok and data available from Genbank were used to identify clades of both viruses. Several contemporary circulating clades of HRSV and HMPV were identified by phylogenetic reconstructions. The molecular epidemiology and evolutionary dynamics of clades were modelled in parallel. Times of origin were determined and positively selected sites were identified. Sustained circulation of contemporary clades of both viruses for decades and their global dissemination demonstrated that switching of the predominant genetic group did not arise through the emergence of novel lineages each respiratory season, but through the fluctuating circulation frequencies of pre-existing lineages which undergo proliferative and eclipse phases. An abundance of sites were identified as positively selected within the G protein but not the F protein of both viruses. For HRSV, these were discordant with previously identified residues under selection, suggesting the virus can evade immune responses by generating diversity at multiple sites within linear epitopes. For both viruses, different sites were identified as positively selected between genetic groups.

Indexed as

Evolution, MolecularAmino Acid SubstitutionBase SequenceGenes, ViralHumansMetapneumovirusParamyxoviridae InfectionsPhylogenyRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsSelection, GeneticViral ProteinsViral Proteins

Identifiers

PMID21390255
PMCPMC3046979
OpenAlexW2151943632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.